Published in J Rheumatol on April 01, 1996
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis (2000) 2.32
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol (1997) 1.66
Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis (2002) 1.57
Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord (2009) 1.40
Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J (1998) 1.29
Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol (1998) 1.24
Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem J (1998) 1.19
Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut (2000) 1.14
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol (1999) 1.10
Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol (1998) 0.98
Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Ann Rheum Dis (2002) 0.87
Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes. Ann Rheum Dis (2001) 0.86
In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage. Ann Rheum Dis (1999) 0.83
Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis. Arthritis Res Ther (2013) 0.77
Dual transcriptome sequencing reveals resistance of TLR4 ligand-activated bone marrow-derived macrophages to inflammation mediated by the BET inhibitor JQ1. Sci Rep (2015) 0.77
MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma. PLoS One (2015) 0.75
Effect of M3 muscarinic acetylcholine receptor deficiency on collagen antibody-induced arthritis. Arthritis Res Ther (2016) 0.75
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet (2002) 6.12
Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet (1998) 4.01
Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (1996) 2.36
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum (2003) 2.20
Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A (1998) 2.16
Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Ann Rheum Dis (2005) 2.15
A genome-wide survey of RAS transformation targets. Nat Genet (2000) 2.06
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]. Z Rheumatol (2012) 1.91
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology (Oxford) (2005) 1.82
Importance of psychological well being and disease activity in termination of an initial DMARD therapy. J Rheumatol (1997) 1.77
[Amendment of the structural quality for inpatient rheumatology. A forward-looking concept]. Z Rheumatol (2011) 1.74
Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis (2004) 1.73
Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology (Oxford) (2002) 1.61
Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome. Arthritis Rheum (1999) 1.56
cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem (1995) 1.54
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis (2004) 1.53
Colour Doppler ultrasonography to detect pannus in knee joint synovitis. Clin Exp Rheumatol (2000) 1.51
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. J Rheumatol (2000) 1.49
[Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies]. Z Rheumatol (2002) 1.39
Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis (2008) 1.39
Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res (1999) 1.37
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) (2008) 1.27
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]. Z Rheumatol (2011) 1.21
Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) (2002) 1.17
Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol (2002) 1.15
Colour duplex sonography of finger arteries in vasculitis and in systemic sclerosis. Ann Rheum Dis (2006) 1.14
Comparative genome sequence analysis of the Bpa/Str region in mouse and Man. Genome Res (2000) 1.13
Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.10
Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.10
[Guideline for the joint swelling symptom--primary physician problem management and referral indications. German Society of Rheumatology "Quality Assurance" Committee]. Z Rheumatol (2000) 1.09
Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem (2000) 1.08
Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics (2010) 1.07
Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations. Clin Rheumatol (2000) 1.02
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res (2000) 1.00
Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum (2000) 0.96
[Infectious bone diseases]. Pathologe (2011) 0.96
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 0.91
Molecular cloning of Xp11 breakpoints in two unrelated mentally retarded females with X;autosome translocations. Cytogenet Cell Genet (2000) 0.91
Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Ann Rheum Dis (2002) 0.87
Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals. Hum Immunol (1999) 0.86
Genomic structure of a novel LIM domain gene (ZNF185) in Xq28 and comparisons with the orthologous murine transcript. Genomics (1997) 0.84
Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford) (2008) 0.82
Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera. J Immunol Methods (2004) 0.81
Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus (2008) 0.78
[Current therapeutic strategy for rheumatoid arthritis]. MMW Fortschr Med (2006) 0.78
[Drug therapy during pregnancy and breast feeding. Updated summary]. Z Rheumatol (2009) 0.78
[Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologics Register RABBIT]. Z Rheumatol (2006) 0.78
[Percutaneous removal of kidney calculi and extracorporeal shockwave lithotripsy in patients with hemorrhagic diatheses]. Z Urol Nephrol (1988) 0.77
[Pregnancy and inflammatory rheumatic diseases]. Z Rheumatol (2010) 0.77
Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis. Clin Exp Rheumatol (2003) 0.77
[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]. Z Rheumatol (2004) 0.76
Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus. Ann Rheum Dis (2006) 0.75
[Leflunomide + methotrexate combination therapy from the physician's viewpoint]. Z Rheumatol (2002) 0.75
[The use of high-resolution color-Doppler sonography in the diagnosis of temporal arteritis]. Rofo (1999) 0.75
[Special problems with long-term studies of SLE]. Z Rheumatol (2002) 0.75
Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew. Agents Actions (1994) 0.75
Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32). Leukemia (2001) 0.75
Therapeutic plasmapheresis and haemostatic system. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 0.75
[Presentation of the Center of Competence in Berlin]. Z Rheumatol (2002) 0.75
[Concomitant dermatitis herpetiformis Duhring, arthritis and Sjögren syndrome in a patient with celiac disease]. Z Rheumatol (1998) 0.75
Hereditary dysfibrinogenaemia: structural and functional studies on three fibrinogen variants. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 0.75
[Rheumatic diseases in pregnancy]. Dtsch Med Wochenschr (2008) 0.75
[Rheumatoid arthritis in the elderly]. Dtsch Med Wochenschr (2009) 0.75
[Reports by the German Society of Rheumatology. Membership meeting of the German Society of Rheumatology e.V. on Friday, 17 September 1999, in Rostock]. Z Rheumatol (1999) 0.75
Genetic analysis of the LGI/Epitempin gene family in sporadic and familial lateral temporal lobe epilepsy. Epilepsy Res (2006) 0.75
[Local intravasal fibrinolysis in acute cerebrovascular occlusions]. Radiol Diagn (Berl) (1989) 0.75
[Thrombotic thrombocytopenic purpura - a rare cause of thrombocytopenia in systemic lupus erythematosus]. Dtsch Med Wochenschr (2002) 0.75
[Peripheral keratinizing ameloblastoma in a dwarf rabbit (Oryctolagus cuniculus f. dom.)]. Tierarztl Prax Ausg K Kleintiere Heimtiere (2014) 0.75
[Clinical aspects and differential diagnostic aspects of rheumatoid arthritis]. Z Arztl Fortbild (Jena) (1987) 0.75
["Don't smoke"--a confirmed factor in the primary prevention of rheumatoid arthritis]. Z Rheumatol (2006) 0.75
[Hypertrophic osteoarthropathy and thrombocytopenia in bronchial carcinoma]. Med Klin (Munich) (2000) 0.75
[Rapid determination of C-reactive protein using latex agglutination]. Zentralbl Gynakol (1989) 0.75
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]. Z Rheumatol (2014) 0.75